COMPLETION OF 2ND TRANCHE OF SHARE BUYBACK

Summary by AI BETAClose X

Reckitt Benckiser Group plc has completed the second tranche of its £1 billion share buyback programme, purchasing 3,461,470 ordinary shares between October 22, 2025, and January 28, 2026, at an average price of £59.46 per share. The company also announced the cancellation of 30 million ordinary shares on December 16, 2025, and an additional 14 ordinary shares on January 13, 2026, and no longer intends to cancel further treasury shares in connection with this tranche.

Disclaimer*

Reckitt Benckiser Group PLC
02 February 2026
 

RECKITT BENCKISER GROUP PLC

 

COMPLETION OF SECOND TRANCHE OF 2025 SHARE BUYBACK PROGRAMME

 

 

Reckitt Benckiser Group plc ("Reckitt" or the "Company") confirms the completion of the second tranche of its £1 billion share buyback programme (the "Programme") announced on 24 July 2025.  

 

Under the Second Tranche, between 22 October 2025 and 28 January 2026, the Company purchased 3,461,470 ordinary shares of 10p each (the "Ordinary Shares") at an average price of £59.46, and which were held in treasury.

 

On 16 December 2025, the Company announced the cancellation of 30 million ordinary shares held in treasury. On 13 January 2026, the Company announced the cancellation of a further 14 ordinary shares held in treasury. Accordingly, the Company no longer intends to cancel further ordinary shares held in treasury in connection with the completion of the second tranche of the Programme.

 

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

 

CONTACT DETAILS:

 

Contacts

 

Nick Ashworth                                                   +44 (0)7408 812350

SVP Investor Relations

 

Catheryn O'Rourke                                             +44 (0) 1753 217 800

General Counsel & Company Secretary

 

About Reckitt

We make the products people trust to care for the ones they love. We are home to some of the world's best-loved consumer health and hygiene brands, including Dettol, Durex, Finish, Gaviscon, Harpic, Lysol, Mucinex, Nurofen, Strepsils, Vanish and Veet. Consumers are at the heart of everything we do. By creating innovative, science-backed solutions, we support people every day to live healthier lives. 

 

Reckitt exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. This commitment goes beyond the products we make. Through our actions, we expand access to healthcare, education and economic opportunities. We support the planet by reducing waste, conserving resources and driving sustainable innovation. 

 

We believe good health starts at home. With every action we take, we strive to make our consumers' lives easier, cleaner and healthier, to strengthen communities and to create a more sustainable future.

 

Find out more or get in touch with us at www.reckitt.com.

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings